Using CT Data to Improve the Quantitative Analysis of 18F-FBB PET Neuroimages
18F-FBB PET is a neuroimaging modality that is been increasingly used to assess brain amyloid deposits in potential patients with Alzheimer's disease (AD). In this work, we analyze the usefulness of these data to distinguish between AD and non-AD patients. A dataset with 18F-FBB PET brain image...
Main Authors: | Fermín Segovia, Raquel Sánchez-Vañó, Juan M. Górriz, Javier Ramírez, Pablo Sopena-Novales, Nathalie Testart Dardel, Antonio Rodríguez-Fernández, Manuel Gómez-Río |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2018.00158/full |
Similar Items
-
High Correlation of Static First-Minute-Frame (FMF) PET Imaging after <sup>18</sup>F-Labeled Amyloid Tracer Injection with [<sup>18</sup>F]FDG PET Imaging
by: Alexander P. Seiffert, et al.
Published: (2021-07-01) -
Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
by: Sarah K. Royse, et al.
Published: (2021-05-01) -
18F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
by: Yan Chang, et al.
Published: (2020-07-01) -
A systematic review and meta‐analysis of 18F‐labeled amyloid imaging in Alzheimer's disease
by: Jing Ming Yeo, et al.
Published: (2015-03-01) -
18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
by: Lucia Baratto, et al.
Published: (2018-07-01)